When Hong Kong Chief Executive Carrie Lam rolled up her shirt sleeve to get the Asian financial hub’s first COVID-19 vaccination last month, she gave a ringing endorsement of the shots produced by mainland Chinese firm Sinovac Biotech Ltd.
“We are taking the Sinovac vaccine today, which was developed and manufactured in the mainland, because this is the first vaccine that has arrived in Hong Kong,” Lam said on Feb. 22 as she got inoculated in a public ceremony with her top aides.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.